Fund Holdings — TCG Crossover Management, LLC

Total Portfolio Value:
$1.26B
Total Bought:
$583.83M
Total Sold:
$290.56M
Net Transaction:
+$293.27M
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
CG Oncology, Inc.COMM(CGON)03,570,206+3,570,206$0$156.73M12.39%+$156.73M
Dyne Therapeutics, Inc.COMM(DYN)1,650,1502,650,150+1,000,000$21.95M$75.24M5.95%+$53.29M
Astria Therapeutics, Inc.COMM05,278,928+5,278,928$0$74.30M5.87%+$74.30M
Silence Therapeutics plcADRS(SLN)2,104,8753,295,350+1,190,475$36.56M$71.18M5.63%+$34.62M
Structure Therapeutics IncADRS2,109,5841,598,421-511,163$85.99M$68.51M5.42%-$17.48M
Aerovate Therapeutics IncCOMM2,201,2742,201,2740$49.81M$65.09M5.15%+$15.28M
Inhibrx,incCOMM1,750,3871,750,3870$66.51M$61.19M4.84%-$5.32M
Keros Therapeutics, Inc.COMM(KROS)0879,344+879,344$0$58.21M4.60%+$58.21M
Geron CorporationCOMM(GERN)23,375,83917,391,639-5,984,200$49.32M$57.39M4.54%+$8.07M
Savara Inc.COMM(SVRA)10,000,00010,000,0000$47.00M$49.80M3.94%+$2.80M
Ocular Therapeutix, Inc.COMM(OCUL)05,319,148+5,319,148$0$48.40M3.83%+$48.40M
Cogent Biosciences, Inc.COMM(COGT)5,631,0426,214,375+583,333$33.11M$41.76M3.30%+$8.65M
Edgewise Therapeutics, Inc.COMM(EWTX)02,272,728+2,272,728$0$41.45M3.28%+$41.45M
Mineralys Therapeutics, Inc.COMM(MLYS)03,185,185+3,185,185$0$41.12M3.25%+$41.12M
Madrigal Pharmaceuticals, Inc.COMM(MDGL)179,917149,283-30,634$41.63M$39.86M3.15%-$1.76M
Tourmaline Bio IncCOMM1,007,9021,477,593+469,691$26.39M$33.84M2.68%+$7.45M
Tyra Biosciences, Inc.COMM(TYRA)1,989,1031,989,1030$27.55M$32.62M2.58%+$5.07M
COMPASS Pathways plcADRS(CMPS)3,858,0003,858,0000$33.76M$32.10M2.54%-$1.66M
Kura Oncology, Inc.COMM(KURA)1,423,6421,423,6420$20.47M$30.37M2.40%+$9.89M
Tarsus Pharmaceuticals, Inc.COMM(TARS)1,142,857793,829-349,028$23.14M$28.86M2.28%+$5.71M
Adverum Biotechnologies, Inc.COMM02,008,340+2,008,340$0$28.40M2.25%+$28.40M
Soleno Therapeutivs, Inc.COMM0550,000+550,000$0$23.54M1.86%+$23.54M
Centessa Pharmaceuticals PlcCOMM2,040,8162,040,8160$16.24M$23.06M1.82%+$6.82M
ABIVAX Société AnonymeADRS(ABVX)1,100,0001,100,0000$11.77M$15.73M1.24%+$3.96M
Vistagen Therapeutics, Inc.COMM(VTGN)2,676,5802,676,5800$13.76M$14.13M1.12%+$374.7K
Kalvista Pharmaceuticals, IncCOMM3,395,4951,163,356-2,232,139$41.59M$13.80M1.09%-$27.80M
C4 Therapeutics, Inc.COMM(CCCC)1,276,5741,276,5740$7.21M$10.43M0.82%+$3.22M
Entrada Therapeutics, Inc.COMM(TRDA)584,955584,9550$8.83M$8.29M0.66%-$538.2K
AN2 Therapeutics, Inc.COMM2,678,2091,555,118-1,123,091$54.88M$5.05M0.40%-$49.82M
Kodiak Sciences Inc.COMM(KOD)267,941899,999+632,058$814.5K$4.73M0.37%+$3.92M
Ventyx Biosciences, IncCOMM815,724815,7240$2.01M$4.49M0.35%+$2.47M
Nektar TherapeuticsCOMM(NKTR)04,000,000+4,000,000$0$3.74M0.30%+$3.74M
Cabaletta Bio, Inc.COMM(CABA)486,79586,795-400,000$11.05M$1.48M0.12%-$9.57M
Gracell Biotechnologies Inc.ADRS4,514,7860-4,514,786$45.33M$0—-$45.33M
Icosavax IncCOMM3,703,7040-3,703,704$58.37M$0—-$58.37M
Nurix Therapeutics, Inc.COMM(NRIX)717,6540-717,654$7.41M$0—-$7.41M
Rayzebio, Inc.COMM869,9080-869,908$54.08M$0—-$54.08M
Taysha Gene Therapies, Inc.COMM(TSHA)2,912,8610-2,912,861$5.16M$0—-$5.16M
Page 1 of 1
TCG Crossover Management, LLC — 13F Holdings — Q1 2024 | TickerTrail